Guerbet is a human-scale company that aims to become a new global leader in medical imaging. Pioneer in contrast media with 90 years' experience, Guerbet is the only pharmaceutical group dedicated to medical imaging worldwide, with a presence in almost 80 countries via a network of subsidiaries and distributors. The company offers a comprehensive range of CT scan, Cath Lab, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostics (IRT) products, along with a range of injectors and related medical devices to improve patients' diagnosis, prognosis and quality of life. Advancing in innovation solutions, the diagnosis of major diseases (cardiovascular diseases, cancers, diseases of the central nervous system) and interventional radiology while reconciling efficacy and cost containment, are at the heart of Guerbet's mission.

Villepinte, FR
Size (employees)
2,521 (est)
Guerbet was founded in 1926 and is headquartered in Villepinte, FR

Guerbet Office Locations

Guerbet has office in Villepinte
Villepinte, FR

Guerbet Metrics

Guerbet Summary

Market capitalization

€1.1 b

Closing share price

Guerbet's current market capitalization is €1.1 b.

Guerbet Financials

Guerbet's revenue is €490.3 m in FY, 2015 which is a 19.7% increase from the previous period.
FY, 2014FY, 2015


€409.7 m€490.3 m

Revenue growth, %


Cost of goods sold

€90.4 m€103.5 m

Gross profit

€319.3 m€386.8 m

Gross profit Margin, %


Sales and marketing expense

€113.3 m€125.6 m

General and administrative expense

€123.4 m€155.9 m

Operating expense total

€255.7 m€304 m

Depreciation and amortization

€24.8 m€26.8 m


€67.7 m€84.4 m

EBITDA margin, %



€38.8 m€56.1 m

EBIT margin, %


Interest expense

€1.9 m€1.2 m

Income tax expense

€10.1 m€18.4 m

Net Income

€26.1 m€39.9 m

Operating cash flow

€60 m€74.3 m

Guerbet Market Value History

Guerbet Revenue Breakdown

Guerbet Online Presence

Guerbet Company Life

You may also be interested in